Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic opportunities and pitfalls in the treatment of axon degeneration

15 Oct 2018

Abstract excerpt

PURPOSE OF REVIEW: The current review analyzes recent findings that suggest that axon degeneration is a druggable process in the treatment of neurodegenerative disorders and a subset of traumas. RECENT FINDINGS: Emerging evidence reveals that axon degeneration is an active and regulated process in the early progression of some neurodegenerative diseases and acute traumas, which is orchestrated through a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Axon Guidance and Neuronal Signaling
Share to Nerve injury and regeneration
Share to Sirtuins and Resveratrol in Medicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30320612
DOI: 10.1097/wco.0000000000000621

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic opportunities and pitfalls in the treatment of axon degenerationPMID 30320612Read ↗

Exploring SARM1 as a target to delay programmed axon degenerationSemantic proximity Read ↗

DLK Activation Synergizes with Mitochondrial Dysfunction to Downregulate Axon Survival Factors and Promote SARM1-Dependent Axon DegenerationSemantic proximity Read ↗

Axon pathology in neurological disease: a neglected therapeutic target.Semantic proximity Read ↗

A Novel NAD Signaling Mechanism in Axon Degeneration and its Relationship to Innate ImmunitySemantic proximity Read ↗

Gene therapy targeting SARM1 blocks pathological axon degeneration in miceSemantic proximity Read ↗

Morphological and Functional Evaluation of Axons and their Synapses during Axon Death in Drosophila melanogaster.Semantic proximity Read ↗

Axon Death Pathways Converge on Axundead to Promote Functional and Structural Axon DisassemblySemantic proximity Read ↗

Small Molecule SARM1 Inhibitors Recapitulate the SARM1-/- Phenotype and Allow Recovery of a Metastable Pool of Axons Fated to Degenerate.Semantic proximity Read ↗

Programmed axon degeneration: from mouse to mechanism to medicineSemantic proximity Read ↗

Inhibiting Axon Degeneration and Synapse Loss Attenuates Apoptosis and Disease Progression in a Mouse Model of Motoneuron DiseaseSemantic proximity Read ↗

Sarm1 Gates the Transition from Protective to Repair Schwann Cell States Following Nerve InjurySemantic proximity Read ↗

dSarm/Sarm1 is required for activation of an injury-induced axon death pathway.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.